NELL-1 promotes cartilage regeneration in an in vivo rabbit model

Tissue Engineering - Part A

Volumn 18, Issue 3-4, 2012, Pages 252-261

  Siu, Ronald K ^a,b   Zara, Janette N ^a,b   Hou, Yaping ^a,b   James, Aaron W ^b   Kwak, Jinny ^b   Zhang, Xinli ^b   Ting, Kang ^b   Wu, Benjamin M ^a   Soo, Chia ^b   Lee, Min ^a,b  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINATE; BODY FLUIDS; CHITOSAN; COLLAGEN; DEFECTS; HYDROGELS; NANOPARTICLES; PEPTIDES; TISSUE; TISSUE ENGINEERING; TRANSCRIPTION FACTORS;

ADVERSE EFFECT; ALGINATE HYDROGELS; BONE MARKERS; CARTILAGE DEFECTS; CARTILAGE REGENERATION; CHITOSAN NANOPARTICLES; CHONDROCYTES; CRANIAL SUTURES; EPIDERMAL GROWTH FACTORS; HISTOLOGICAL ANALYSIS; IMMUNOHISTOCHEMISTRY; IN-VITRO; IN-VIVO; NEURAL TISSUE; NEW ZEALAND WHITE RABBIT; OSTEOCHONDRAL; OSTEOCHONDRAL DEFECTS; POST-IMPLANTATION; RABBIT MODELS; TYPE I COLLAGEN; TYPE II COLLAGENS;

CARTILAGE;

ORYCTOLAGUS CUNICULUS;

ALGINIC ACID; NELL1 PROTEIN, HUMAN; NERVE PROTEIN;

ANIMAL; ARTICLE; CARTILAGE; CATTLE; CHEMISTRY; CHO CELL; CRICETULUS; DISEASE MODEL; DRUG EFFECT; HAMSTER; HUMAN; HYDROGEL; IMMUNOHISTOCHEMISTRY; IMPLANT; KINETICS; PATHOLOGY; PHYSIOLOGY; RABBIT; REGENERATION; STAINING;

ALGINATES; ANIMALS; CARTILAGE; CATTLE; CHO CELLS; CRICETINAE; CRICETULUS; DISEASE MODELS, ANIMAL; HUMANS; HYDROGEL; IMMUNOHISTOCHEMISTRY; IMPLANTS, EXPERIMENTAL; KINETICS; NERVE TISSUE PROTEINS; RABBITS; REGENERATION; STAINING AND LABELING;

EID: 84856289435     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0142     Document Type: Article

References (61)

1. From the Centers for Disease Control and Prevention. Arthritis prevalence and activity limitations-United States, 1990. JAMA 272, 346, 1994.
2. Laurencin, C.T., Ambrosio, A.M., Borden, M.D., and Cooper, J.A., Jr. Tissue engineering: orthopedic applications. Ann Rev Biomed Eng 1, 19, 1999.
3. Saraf, A., and Mikos, A.G. Gene delivery strategies for cartilage tissue engineering. Adv Drug Deliv Rev 58, 592, 2006.
4. Jackson, D.W., Simon, T.M., and Aberman, H.M. Symptomatic articular cartilage degeneration: the impact in the new millennium. Clin Orthop Relat Res (391Suppl), S14, 2001.
5. McPherson, J.M., and Tubo, R. Articular cartilage injury. In: Lanza, R.P., Langer, R., Vacanti, J., eds. Principles of Tissue Engineering, 2nd ed. San Diego: Academic Press, 2000, pp. 697-709.
6. Hunziker, E.B. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage 10, 432, 2001.
7. Vinatier, C., Mrugala, D., Jorgensen, C., Guicheux, J., and Noel, D. Cartilage engineering: a crucial combination of cells, biomaterials and biofactors. Trends Biotechnol 27, 307, 2009.
8. Benya, P.D., and Shaffer, J.D. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 30, 215, 1982.
9. Benya, P.D., Padilla, S.R., and Nimni, M.E. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell 15, 1313, 1978.
10. Chubinskaya, S., and Kuettner, K.E. Regulation of osteogenic proteins by chondrocytes. Int J Biochem Cell B 35, 1323, 2003.
11. Yang, W.D., Gomes, R.R., Brown, A.J., Burdett, A.R., Alicknavitch, M., Farach-Carson, M.C., et al. Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenetic protein-2-based matrices. Tissue Eng 12, 2009, 2006.
12. Grunder, T., Gaissmaier, C., Fritz, J., Stoop, R., Hortschansky, P., Mollenhauer, J., and Aicher, W.K. Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads. Osteoarthritis Cartilage 12, 559, 2004.
13. Redini, F., Daireaux, M., Mauviel, A., Galera, P., Loyau, G., and Pujol, J.P. Characterization of proteoglycans synthesized by rabbit articular chondrocytes in response to transforming growth factor-beta (TGF-beta). Biochim Biophys Acta 1093, 196, 1991.
14. Ducy, P., and Karsenty, G. The family of bone morphogenetic proteins. Kidney Int 57, 2207, 2000.
15. Van Beuningen, H.M., Glansbeek, H.L., van der Kraan, P.M., and van den Berg, W.B. Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cartilage 6, 306, 1998.
16. Yeh, T.T., Wu, S.S., Lee, C.H., Wen, Z.H., Lee, H.S., Yang, Z., et al. The short-term therapeutic effect of recombinant human bone morphogenetic protein-2 on collagenase-induced lumbar facet joint osteoarthritis in rats. Osteoarthritis Cartilage 15, 1357, 2007.
17. Blaney Davidson, E.N., van der Kraan, P.M., and van den Berg, W.B. TGF-beta and osteoarthritis. Osteoarthritis Cartilage 15, 597, 2007.
18. Bakker, A.C., van de Loo, F.A., van Beuningen, H.M., Sime, P., van Lent, P.L., van der Kraan, P.M., et al. Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation. Osteoarthritis Cartilage 9, 128, 2001.
19. van Beuningen, H.M., van der Kraan, P.M., Arntz, O.J., and van den Berg, W.B. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 71, 279, 1994.
20. van der Kraan, P.M., and van den Berg, W.B. Osteophytes: relevance and biology. Osteoarthritis Cartilage 15, 237, 2007.
21. Ting, K., Vastardis, H., Mulliken, J.B., Soo, C., Tieu, A., Do, H., et al. Human NELL-1 expressed in unilateral coronal synostosis. J Bone Miner Res 14, 80, 1999.
22. Siu, R.K., Lu, S.S., Li, W., Whang, J., McNeill, G., Zhang, X., et al. NELL-1 protein promotes bone formation in a sheep spinal fusion model. Tissue Eng Part A 17, 1123, 2011.
23. Aghaloo, T., Cowan, C.M., Chou Y-F, Zhang, X., Lee, H., Miao, S., et al. NELL-1-induced bone regeneration in calvarial defects. Am J Pathol 169, 903, 2006.
24. Cowan, C.M., Cheng, S., Ting, K., Soo, C., Walder, B., Wu, B., et al. NELL-1 induced bone formation within the distracted intermaxillary suture. Bone 38, 48, 2006.
25. Li, W., Lee, M., Whang, J., Siu, R.K., Zhang, X., Liu, C., et al. Delivery of lyophilized NELL-1 in a rat spinal fusion model. Tissue Eng Part A 16, 2861, 2010.
26. Li, W., Zara, J.N., Siu, R.K., Lee, M., Aghaloo, T., Zhang, X., et al. NELL-1 enhances bone regeneration in a rat criticalsized femoral segmental defect model. Plast Reconstr Surg 127, 580, 2011.
27. Truong, T., Zhang, X., Pathmanathan, D., Soo, C., and Ting, K. Craniosynostosis-associated gene NELL-1 is regulated by Runx2. J Bone Miner Res 22, 7, 2007.
28. Komori, T. Regulation of bone development and extracellular matrix protein genes byRUNX2. Cell Tissue Res 339, 189, 2010.
29. Desai, J., Shannon, M.E., Johnson, M.D., Ruff, D.W., Hughes, L.A., Kerley, M.K., et al. Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects. Hum Mol Genet 15, 1329, 2006.
30. Dragoo, J.L., Carlson, G., McCormick, F., Khan-Farooqi, H., Zhu, M., Zuk, P.A., and Benhaim, P. Healing full-thickness cartilage defects using adipose-derived stem cells. Tissue Eng 13, 1615, 2007.
31. Lee, M., Siu, R.K., Ting, K., and Wu, B.M. Effect of NELL-1 delivery on chondrocyte proliferation and cartilaginous extracellularmatrix deposition. Tissue Eng Part A 16, 1791, 2010.
32. Gonzalez-Rodriguez, M.L., Holgado, M.A., Sanchez-Lafuente, C., Rabasco, A.M., and Fini, A. Alginate/chitosan particulate systems for sodium diclofenac release. Int J Pharm 232, 225, 2002.
33. Mankin, H.J., Dorfman, H., Lippiello, L., and Zarins, A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 53, 523, 1971.
34. Lu, S.S., Whang, J., Zhang, X., Wu, B., Turner, A.S., Seim, H.B., et al. NELL-1 promotes bone formation in a sheep spinal fusion model. J Bone Miner Res 23, S171, 2007.
35. Yoshida, C.A., Yamamoto, H., Fujita, T., Furuichi, T., Ito, K., Inoue, K., et al. Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev 18, 952, 2004.
36. Inada, M., Yasui, T., Nomura, S., Miyake, S., Deguchi, K., Himeno, M., et al. Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn 214, 279, 1999.
37. Sato, S., Kimura, A., Ozdemir, J., Asou, Y., Miyazaki, M., Jinno, T., et al. The distinct role of the Runx proteins in chondrocyte differentiation and intervertebral disc degeneration: findings in murine models and in human disease. Arthritis Rheum 58, 2764, 2008.
38. Zhang, X., Peault, B., Chen, W., Li, W., Corselli, M., James, A.W., et al. The NELL-1 growth factor stimulates bone formation by purified human perivascular cells. Tissue Eng Part A 2011 [Epub ahead of print].
39. Aghaloo, T., Jiang, X., Soo, C., Zhang, Z., Zhang, X., Hu, J., et al. A study of the role of NELL-1 gene modified goat bone marrow stromal cells in promoting new bone formation. Mol Ther 15, 1872, 2007.
40. Zhang, X., Carpenter, D., Bokui, N., Soo, C., Miao, S., Truong, T., et al. Overexpression of NELL-1, a craniosynostosis-associated gene, induces apoptosis in osteoblasts during craniofacial development. J BoneMiner Res 18, 2126, 2003.
41. Zhang, X., Kuroda, S., Carpenter, D., Nishimura, I., Soo, C., Moats, R., et al. Craniosynostosis in transgenic mice overexpressing NELL-1. J Clin Invest 110, 861, 2002.
42. Chen, W., Zhang, X., Siu, R.K., Chen, F., Shen, J., Zara, J.N., et al. Nfatc2 is a primary response gene of NELL-1 regulating chondrogenesis in ATDC5 cells. J Bone Miner Res 26, 1230, 2011.
43. Hinoi, E., Bialek, P., Chen, Y.T., Rached, M.T., Groner, Y., Behringer, R.R., et al. Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium. Genes Dev 20, 2937, 2006.
44. Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J.M., Behringer, R.R., et al. The novel zinc finger-containing transcription factor Osterix is required for osteoblast differentiation and bone formation. Cell 108, 17, 2002.
45. Uludag, H., D'Augusta, D., Palmer, R., Timony, G., and Wozney, J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J Biomed Mater Res 46, 193, 1999.
46. Walker, D.H., and Wright, N.M. Bone morphogenetic proteins and spinal fusion. Neurosurg Focus 13, 1, 2002.
47. Langer, R., and Vacanti, J.P. Tissue engineering. Science (New York, NY) 260, 920, 1993.
48. Mierisch, C.M., Cohen, S.B., Jordan, L.C., Robertson, P.G., Balian, G., and Diduch, D.R. Transforming growth factorbeta in calcium alginate beads for the treatment of articular cartilage defects in the rabbit. Arthroscopy 18, 892, 2002.
49. Hoemann, C.D., Sun, J., Legare, A., McKee, M.D., and Buschmann, M.D. Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle. Osteoarthritis Cartilage 13, 318, 2005.
50. Hoemann, C.D., Hurtig, M., Rossomacha, E., Sun, J., Chevrier, A., Shive, M.S., and Buschmann, M.D. Chitosanglycerol phosphate/blood implants improve hyaline cartilage repair in ovine microfracture defects. J Bone Joint Surg 87, 2671, 2005.
51. Hoemann, C.D., Sun, J., McKee, M.D., Chevrier, A., Rossomacha, E., Rivard, G.-E., Hurtig, M., and Buschmann, M.D. Chitosan-glycerol phosphate/blood implants elicit hyaline cartilage repair integrated with porous subchondral bone in microdrilled rabbit defects.OsteoarthritisCartilage 15, 78, 2007.
52. Moriya, T., Wada, Y., Watanabe, A., Sasho, T., Nakagawa, K., Mainil-Varlet, P., et al. Evaluation of reparative cartilage after autologous chondrocyte implantation for osteochondritis dissecans: histology, biochemistry, and MR imaging. J Orthop Sci 12, 265, 2007.
53. Fragonas, E., Valente, M., Pozzi-Mucelli, M., Toffanin, R., Rizzo, R., Silvestri, F., et al. Articular cartilage repair in rabbits by using suspensions of allogenic chondrocytes in alginate. Biomaterials 21, 795, 2000.
54. Lin, L., Zhou, C., Wei, X., Hou, Y., Zhao, L., Fu, X., et al. Articular cartilage repair using dedifferentiated articular chondrocytes and bone morphogenetic protein 4 in a rabbit model of articular cartilage defects. Arthritis Rheum 58, 1067, 2008.
55. Pei, M., He, F., Boyce, B.M., and Kish, V.L. Repair of fullthickness femoral condyle cartilage defects using allogeneic synovial cell-engineered tissue constructs. Osteoarthritis Cartilage 17, 714, 2009.
56. Chen, J., Wang, C., Lu, S., Wu, J., Guo, X., Duan, C., et al. In vivo chondrogenesis of adult bone-marrow-derived autologous mesenchymal stem cells. Cell Tissue Res 319, 429, 2005.
57. Yoo, J.U., Barthel, T.S., Nishimura, K., Solchaga, L., Caplan, A.I., Goldberg, V.M., et al. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 80, 1745, 1998.
58. Hwang, N.S., Varghese, S., Lee, H.J., Zhang, Z., Ye, Z., Bae, J., et al. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci USA 105, 20641, 2008.
59. Toh, W.S., Lee, E.H., Guo, X.M., Chan, J.K., Yeow, C.H., Choo, A.B., et al. Cartilage repair using hyaluronan hydrogel-encapsulated human embryonic stem cell-derived chondrogenic cells. Biomaterials 31, 6968, 2010.
60. Kamekura, S., Hoshi, K., Shimoaka, T., Chung, U., Chikuda, H., Yamada, T., et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage 13, 632, 2005.
61. Yoshioka, M., Coutts, R.D., Amiel, D., and Hacker, S.A. Characterization of a model of osteoarthritis in the rabbit knee. Osteoarthritis Cartilage 4, 87, 1996.